Advertisement
Journal Home
Search for

Volume 78, Issue 2, Pages 158-165 (July 2008)


View previous. 11 of 14 View next.

The HLA-G 14bp gene polymorphism and decidual HLA-G 14bp gene expression in pre-eclamptic and normal pregnancies

Ann-Charlotte IversenaCorresponding Author Information1email address, Olav Toai Duc Nguyena1, Linda Føll Tømmerdala, Irina Poliakova Eideab, Veslemøy Malm Landsemc, Nuray Acard, Ronny Myhrec, Helge Klunglandc, Rigmor Austgulena

Received 4 December 2007; received in revised form 30 January 2008; accepted 3 March 2008. published online 18 April 2008.

Abstract 

Trophoblast expression of the non-classical MHC, HLA-G, is considered essential for feto-maternal immune tolerance and successful placentation in pregnancy. The HLA-G 14bp polymorphism in the 3′-untranslated region (UTR) of the HLA-G gene has been reported to be associated with development of pre-eclampsia (PE). In this study, maternal (peripheral blood, n=54) and fetal (cord blood, n=57) HLA-G 14bp genotypes have been determined by PCR in pre-eclamptic and normal pregnancies. In addition, HLA-G 14bp gene expression in decidua basalis (n=59) was analyzed by RT-PCR. The pre-eclamptic syndrome was neither associated with the HLA-G 14bp genotype (maternal or fetal), nor with altered decidual HLA-G 14bp gene expression. Furthermore, the HLA-G 14bp mRNA expressed in decidua basalis was of fetal origin and all potential transcripts, as predicted from the fetal HLA-G 14bp genotype, were expressed. In contrast to previous findings, we found no correlation between the HLA-G 14bp polymorphism and fetal growth. In conclusion, the fetal HLA-G 14bp genotype is reflected in the decidual HLA-G mRNA splice form profile, but does not appear to be associated with increased risk for development of PE.

a Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Women and Children's Centre, Trondheim, Norway

b Department of Obstetrics and Gynecology, St. Olav Hospital, Trondheim University Hospital, Trondheim, Norway

c Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine, Norwegian University of Science and Technology, Women and Children's Centre, Trondheim, Norway

d Department of Histology and Embryology, Faculty of Medicine, Akdeniz University, Antalya, Turkey

Corresponding Author InformationCorresponding author at: Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Women and Children's Centre, Olav Kyrres gt11, N-7006 Trondheim, Norway. Tel.: +47 72573305; fax: +47 72574704.

1 These authors contributed equally to this work.

PII: S0165-0378(08)00024-7

doi:10.1016/j.jri.2008.03.001


View previous. 11 of 14 View next.

Advertisement